NCT02673775

Brief Summary

The purpose of the study is to better understand the mechanisms of lung injury from ozone exposure. Subjects will participate in two exposure sessions: filtered air and 0.2 ppm ozone. Subjects will be asked to produce sputum through coughing after each exposure. The samples will be analyzed for macrophage activity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
135

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 29, 2016

Completed
3 days until next milestone

Study Start

First participant enrolled

February 1, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 4, 2016

Completed
6.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 7, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 7, 2022

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

October 11, 2023

Completed
Last Updated

September 25, 2025

Status Verified

September 1, 2025

Enrollment Period

6.4 years

First QC Date

January 29, 2016

Results QC Date

July 17, 2023

Last Update Submit

September 23, 2025

Conditions

Keywords

Macrophage

Outcome Measures

Primary Outcomes (3)

  • Concentrations of M1 and M2 Macrophages in the Sputum 24 Hours After Exposure.

    The relative concentrations of M1 and M2 macrophages in the induced sputum sample will be assessed.

    24 hours after exposure.

  • Concentrations of M1 and M2 Macrophages in the Sputum 48 Hours After Exposure.

    The relative concentrations of M1 and M2 macrophages in the induced sputum sample will be assessed.

    48 hours after exposure

  • Concentrations of M1 and M2 Macrophages in the Sputum 72 Hours After Exposure.

    Relative concentrations of M1 and M2 macrophages in the induced sputum sample will be assessed.

    72 hours after exposure.

Study Arms (2)

Clean Air

PLACEBO COMPARATOR

Subjects will be exposed to clean air for 3 hours.

Other: Clean Air

Ozone

EXPERIMENTAL

Subjects will be exposed to 0.2 ppm ozone for 3 hours.

Other: Ozone

Interventions

Subjects will have the clean air exposure first, followed by the ozone exposure

Clean Air
OzoneOTHER

Subjects will have the ozone exposure first, followed by the clean air exposure

Ozone

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy men and women

You may not qualify if:

  • Cardiovascular disease
  • Respiratory disease
  • Diabetes
  • Pregnancy
  • HIV infection
  • History of smoking within the last 5 years
  • Daily use of antioxidant supplements (e.g., Vitamin C/E, selenium, beta-carotene, lycopene, lutein, zeaxanthin, or ginkgo biloba)
  • Orthopedic or rheumatological conditions that would interfere with cycle use

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Environmental and Occupational Health Sciences Institute

Piscataway, New Jersey, 08854, United States

Location

MeSH Terms

Interventions

Environment, ControlledOzone

Intervention Hierarchy (Ancestors)

EnvironmentEnvironment and Public HealthOxygenGasesInorganic Chemicals

Results Point of Contact

Title
Andrew Gow, PhD
Organization
Rutgers, the State University of New Jersey

Study Officials

  • Howard M. Kipen, MD, MPH

    Rutgers School of Public Health

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 29, 2016

First Posted

February 4, 2016

Study Start

February 1, 2016

Primary Completion

June 7, 2022

Study Completion

June 7, 2022

Last Updated

September 25, 2025

Results First Posted

October 11, 2023

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

The individual data will be confidential.

Locations